COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 211.4 | 3 | 0189-0702 | 238.41 | 702.66 | 741 | 105.40 | 0.838 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 188.4 | 4 | 0001-0029 | 376.31 | 29.33 | 422 | 79.50 | 0.839 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1172.2 | 4 | 0002-0030 | 469.53 | 29.71 | 401 | 77.50 | 0.839 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 199.8 | 4 | 0003-0032 | 326.73 | 31.62 | 416 | 76.67 | 0.889 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 166.2 | 4 | 0004-0035 | 166.80 | 35.50 | 385 | 74.67 | 0.868 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 201.3 | 4 | 0005-0034 | 539.01 | 34.48 | 445 | 82.43 | 0.823 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 240.7 | 4 | 0006-0034 | 38.45 | 34.57 | 375 | 74.33 | 0.853 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 231.7 | 4 | 0007-0036 | 206.75 | 36.76 | 415 | 80.57 | 0.803 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 199.3 | 4 | 0008-0042 | 639.40 | 41.71 | 375 | 73.50 | 0.872 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 286.9 | 4 | 0009-0047 | 481.05 | 47.22 | 481 | 85.98 | 0.818 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 222.8 | 4 | 0010-0051 | 403.40 | 51.21 | 468 | 82.33 | 0.868 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 179.0 | 4 | 0011-0061 | 606.13 | 61.23 | 465 | 82.08 | 0.867 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 229.2 | 4 | 0012-0061 | 870.01 | 62.05 | 423 | 76.67 | 0.904 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 237.9 | 4 | 0013-0064 | 814.30 | 64.40 | 384 | 72.77 | 0.911 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.0 | 4 | 0014-0070 | 776.89 | 69.91 | 432 | 80.08 | 0.846 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 223.6 | 4 | 0015-0069 | 362.99 | 69.22 | 421 | 80.33 | 0.820 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 400.2 | 4 | 0016-0075 | 690.51 | 75.10 | 436 | 78.43 | 0.891 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 245.3 | 4 | 0017-0076 | 236.77 | 76.65 | 410 | 77.50 | 0.858 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 206.4 | 4 | 0018-0077 | 538.56 | 77.41 | 475 | 87.15 | 0.786 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 469.3 | 4 | 0019-0084 | 839.75 | 83.66 | 374 | 72.77 | 0.888 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 207.5 | 4 | 0020-0087 | 511.66 | 87.27 | 484 | 87.15 | 0.801 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.2 | 4 | 0021-0100 | 67.65 | 99.83 | 411 | 77.26 | 0.865 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 232.6 | 4 | 0022-0102 | 191.26 | 101.85 | 442 | 80.67 | 0.854 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 223.3 | 4 | 0023-0106 | 411.29 | 105.96 | 766 | 104.91 | 0.875 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 262.9 | 4 | 0024-0103 | 436.90 | 103.15 | 459 | 81.36 | 0.871 |